Knowledge IVD Development What causes pseudohyponatremia, and how to calibrate direct ISE assays? Ensure IVD Accuracy
Author avatar

Tech Team · CamelBio

Updated 1 month ago

What causes pseudohyponatremia, and how to calibrate direct ISE assays? Ensure IVD Accuracy


Pseudohyponatremia is a measurement artifact, not a true electrolyte disorder. It arises when indirect ion-selective electrode (ISE) methods are used to test plasma samples that contain abnormally high concentrations of lipids or proteins. In these methods, a pre‑analytical dilution step assumes a normal ratio of plasma water to solids; elevated macromolecules physically displace the water phase, causing the instrument to report a falsely low sodium concentration. Direct ISE assays avoid this entirely by measuring ion activity in the undiluted sample. To ensure direct ISE results remain clinically comparable to established reference intervals, calibration standards must be formulated with an ionic strength and composition that closely matches normal blood plasma (typically adjusted to ~0.160 mol/kg).

The root cause is the electrolyte exclusion effect: lipids and proteins occupy volume without contributing to the sodium‑containing water phase. Direct ISE sidesteps this by analyzing the water phase directly, but only if its calibrators mirror the ionic milieu of plasma – otherwise a systematic bias can creep in and undermine clinical accuracy.

Understanding Pseudohyponatremia: The Volume Displacement Artifact

Normal Plasma Water Fraction

Normal plasma is approximately 93% water and 7% solids (mainly proteins and lipids).
Sodium ions reside exclusively in the aqueous phase.
Any method that calculates concentration relative to total sample volume depends on this standard 93:7 ratio.

How Indirect ISE Creates the False Low

Indirect ISE methods dilute the sample before measurement and assume a fixed volume of plasma water per unit of total sample.
When solids such as lipids or proteins increase, the actual water volume shrinks; the dilution step then spreads the same absolute amount of sodium into a larger total fluid volume, yielding a lower apparent concentration.
The electrode “sees” a normal ion activity in the water phase, but the instrument’s algorithm wrongly interprets it as whole‑sample concentration – producing pseudohyponatremia.

Clinical Triggers

Severe hypertriglyceridemia (typically triglycerides ≥1500 mg/dL) and hyperproteinemia (e.g., multiple myeloma with high monoclonal immunoglobulin levels) are the classic culprits.
In both scenarios, the solid fraction expands well beyond 7%, displacing plasma water and triggering the artifact.
The resulting sodium value is physiologically misleading and can lead to unnecessary intervention if not recognized.

Direct ISE: Eliminating the Displacement Error

The Principle of Direct Measurement

Direct ISE measures ion activity in the water phase of an undiluted sample.
A membrane electrode is exposed to the raw plasma, and the generated potential is determined solely by the sodium activity in that water compartment.
Because no pre‑analytical dilution is performed, the electrode does not care how much lipid or protein surrounds the water – it sees only the ion activity.

Why Direct ISE Is Immune to the Artifact

Since the sensor reads activity directly, the measurement reflects the true physiological sodium status.
Even if the water phase is reduced to 70% of total volume, the activity inside that water remains constant, and the electrode output stays unchanged.
Thus, direct ISE sidesteps the electrolyte exclusion effect that plagues indirect methods.

Calibrating Direct ISE: The Matrix Matching Imperative

Why Calibration Is Critical for Clinical Reporting

Direct ISE measures ion molality (activity per mass of water), while clinical reference intervals are expressed as molarity (concentration per volume of plasma).
To bridge this gap without recalculating every result, the calibration standards must create an electrochemical environment identical to that of normal plasma.
When done correctly, the instrument can directly report a concentration that aligns with flame‑photometry‑derived reference ranges.

Ionic Strength and Composition Requirements

The primary reference specifies that calibrators for direct ISE should be adjusted to an ionic strength of approximately 0.160 mol/kg.
Inert electrolytes and buffer salts are added to mimic the ionic background of plasma, ensuring that the activity coefficient of sodium in the calibrator matches that in a typical patient sample.
This matrix matching is essential because the Nikolsky‑Eisenman equation (the foundation of ISE potentiometry) relates measured potential to ion activity; only when activity coefficients are equal does the same potential correspond to the same concentration.

How That Matches the Nikolsky‑Eisenman Equation

The electrode potential depends logarithmically on activity, not concentration.
If the calibrator’s activity coefficient differs from the sample’s, a fixed potential offset is introduced, producing a systematic bias in the reported concentration.
By equalizing the ionic strength and composition, the activity coefficient of the analyte ion is standardized, allowing a straightforward calculation of concentration directly from the calibration curve – without empirical correction factors.

Understanding the Trade-offs

The Calibration Sensitivity

While direct ISE eliminates pseudohyponatremia, it becomes exquisitely sensitive to the formulation of its calibration solutions.
A mismatch in ionic strength, the choice of background electrolyte, or even the pH buffer can shift the liquid‑junction potential and alter the sodium reading.
This demands rigorous quality control and strict adherence to the specified matrix – a subtlety that indirect methods, with their large dilution, can sometimes tolerate more easily.

Clinical Relevance vs. Standardization

Direct ISE values inherently reflect plasma‑water sodium, which is physiologically the most relevant measure.
However, many clinical guidelines and electronic decision‑support tools were built on indirect ISE or flame photometry data.
Thus, assay developers must intentionally design calibration matrices so that direct ISE outputs appear equivalent to those older methods (i.e., “flame‑equivalent” results) – otherwise, physicians might misinterpret a perfectly accurate direct‑ISE reading as hyper‑ or hyponatremia.

Not a Universal Panacea

Direct ISE does not correct for all forms of hyponatremia; it only avoids the lipid‑protein displacement artifact.
True sodium disturbances (e.g., from hyperglycemia‑induced water shifts) will still be measured accurately, because the direct reading reflects the physiological ion activity.
The responsibility falls on the laboratory director to correctly interpret any remaining discrepancies between direct and indirect values, especially in patients without elevated lipids or proteins.

Making the Right Choice for Electrolyte Testing

The decision between indirect and direct ISE – and the calibration strategy – depends on your clinical and operational priorities.

  • If your primary focus is eliminating pseudohyponatremia in high‑risk populations: Use a direct ISE system calibrated with ionic‑strength‑matched standards (~0.160 mol/kg, plasma‑like composition). This will provide accurate sodium results regardless of lipid or protein load.
  • If your primary focus is maintaining backward compatibility with historical reference intervals: Ensure the calibrator matrix takes into account the normal water displacement of plasma (the 93% water factor) so that direct ISE readings track with legacy flame‑photometry or indirect‑ISE databases.
  • If you are developing an IVD electrolyte analyzer: Engineer the calibration fluid with precise ionic composition and verify that the potential‑concentration relationship follows the Nikolsky‑Eisenman equation without a matrix offset; otherwise, you risk systematic bias that can confound clinical interpretation.

A well‑designed direct ISE assay, anchored by a plasma‑identical calibration matrix, gives you the best of both worlds: freedom from pseudohyponatremia and a result that clinicians can trust.

Summary Table:

Feature / Aspect Indirect ISE Assay Direct ISE Assay
Sample Preparation Pre-analytical dilution Undiluted raw plasma/blood
Measurement Basis Ion concentration per total volume Ion activity in plasma water
Artifact Risk High (volume displacement by lipids/proteins) Immune to pseudohyponatremia
Calibration Key Need Tolerates mild matrix variations Strict ionic strength (~0.160 mol/kg) matching

Optimize Your Direct ISE Assay Development with CamelBio

Eliminating measurement artifacts like pseudohyponatremia requires precise calibrator formulations and uncompromising assay standards. CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to premium IVD raw materials, technical services, and expert consulting—covering every stage from concept to clinic.

Contact CamelBio today to refine your electrolyte assay performance and deliver precise, clinically trusted results.


Leave Your Message